Picture of Halma logo

HLMA Halma News Story

0.000.00%
gb flag iconLast trade - 00:00
TechnologyBalancedLarge CapHigh Flyer

REG - Halma PLC - Half-year Report <Origin Href="QuoteRef">HLMA.L</Origin> - Part 2

- Part 2: For the preceding part double click  ID:nRSU0273Xa 

              -                       (265)       
 Tax relating to components of other comprehensive income and expense       -                                      -                           -               -                                51                   -                        -                    (667)                   (616)       
 Total other comprehensive income and expense                               -                                      -                           -               -                                (214)                (36,687)                 -                    2,839                   (34,062)    
 Dividends paid                                                             -                                      -                           -               -                                -                    -                        -                    (31,733)                (31,733)    
 Share-based payments charge                                                -                                      -                           -               -                                -                    -                        3,532                -                       3,532       
 Deferred tax on share-based                                                -                                      -                           -               -                                -                    -                        (563)                -                       (563)       
 payment transactions                                                                                                                                                                                                                                                                                  
 Excess tax deductions related to share-based payments on exercised awards  -                                      -                           -               -                                -                    -                        -                    1,135                   1,135       
 Performance share plan awards vested                                       -                                      -                           3,594           -                                -                    -                        (6,940)              -                       (3,346)     
 At 30 September 2017 (unaudited)                                           37,965                                 23,608                      (3,669)         185                              140                  113,510                  (10,294)             613,870                 775,315     
 
 
 Own shares are ordinary shares in Halma plc purchased by the Company and held to fulfil the Company's obligations under the Company's share plans. As at 30 September 2017 the number of treasury shares held was 3,990 (1 October 2016: 462,188; 1 April 2017: 462,188) and the number of shares held by the Employee Benefit Trust was 421,991 (1 October 2016: 262,417 and 1 April 2017: 512,417).  
 
 
                                                                                                For the 26 weeks to 1 October 2016  
                                                                            Share capital £000  Share premiumaccount £000           Ownshares £000  Capital redemption reserve £000  Hedging reserve £000  Translation reserve£000  Other reserves £000  Retained earnings £000  Total £000  
 At 2 April 2016 (audited)                                                  37,965              23,608                              (8,219)         185                              (610)                 75,387                   (5,831)              523,855                 646,340     
 Profit for the period                                                      -                   -                                   -               -                                -                     -                        -                    52,212                  52,212      
 Other comprehensive income and expense:                                                                                                                                                                                                                                                     
 Exchange differences on translation of foreign operations                  -                   -                                   -               -                                -                     57,825                   -                    -                       57,825      
 Actuarial losses on defined benefit pension plans                          -                   -                                   -               -                                -                     -                        -                    (45,838)                (45,838)    
 Effective portion of changes in fair value of cash flow hedges             -                   -                                   -               -                                (453)                 -                        -                    -                       (453)       
 Tax relating to components of other comprehensive income and expense       -                   -                                   -               -                                91                    -                        -                    9,168                   9,259       
 Total other comprehensive income and expense                               -                   -                                   -               -                                (362)                 57,825                   -                    (36,670)                20,793      
 Dividends paid                                                             -                   -                                   -               -                                -                     -                        -                    (29,609)                (29,609)    
 Share-based payments charge                                                -                   -                                   -               -                                -                     -                        3,110                -                       3,110       
 Deferred tax on share-based payment transactions                           -                   -                                   -               -                                -                     -                        (127)                -                       (127)       
 Excess tax deductions related to share-based payments on exercised awards  -                   -                                   -               -                                -                     -                        -                    1,159                   1,159       
 Performance share plan awards vested                                       -                   -                                   3,323           -                                -                     -                        (6,633)              -                       (3,310)     
 At 1 October 2016 (unaudited)                                              37,965              23,608                              (4,896)         185                              (972)                 133,212                  (9,481)              510,947                 690,568     
 
 
                                                                                                For the 52 weeks to 1 April 2017  
                                                                            Share capital £000  Share premiumaccount £000         Ownshares £000  Capital redemption reserve £000  Hedgingreserve£000  Translation reserve£000  Other reserves £000  Retained earnings £000  Total £000  
 At 2 April 2016 (audited)                                                  37,965              23,608                            (8,219)         185                              (610)               75,387                   (5,831)              523,855                 646,340     
 Profit for the period                                                      -                   -                                 -               -                                -                   -                        -                    129,689                 129,689     
 Other comprehensive income and expense:                                                                                                                                                                                                                                                 
 Exchange differences on translation of foreign operations                  -                   -                                 -               -                                -                   74,810                   -                    -                       74,810      
 Actuarial losses on defined benefit pension plans                          -                   -                                 -               -                                -                   -                        -                    (31,059)                (31,059)    
 Effective portion of changes in fair value of cash flow hedges             -                   -                                 -               -                                1,197               -                        -                    -                       1,197       
 Tax relating to components of other comprehensive income and expense       -                   -                                 -               -                                (233)               -                        -                    6,082                   5,849       
 Total other comprehensive income and expense                               -                   -                                 -               -                                964                 74,810                   -                    (24,977)                50,797      
 Dividends paid                                                             -                   -                                 -               -                                -                   -                        -                    (49,788)                (49,788)    
 Share-based payments charge                                                -                   -                                 -               -                                -                   -                        6,076                -                       6,076       
 Deferred tax on share-based payment transactions                           -                   -                                 -               -                                -                   -                        65                   -                       65          
 Excess tax deductions related to share-based payments on exercised awards  -                   -                                 -               -                                -                   -                        -                    1,135                   1,135       
 Purchase of Own shares                                                     -                   -                                 (2,368)         -                                -                   -                        -                    -                       (2,368)     
 Performance share plan awards vested                                       -                   -                                 3,324           -                                -                   -                        (6,633)              -                       (3,309)     
 At 1 April 2017 (audited)                                                  37,965              23,608                            (7,263)         185                              354                 150,197                  (6,323)              579,914                 778,637     
 
 
 Consolidated Cash Flow Statement                                                                                                                                                                                                  
                                                          Notes                                       Unaudited 6 months to 30 September 2017£000  Unaudited 26 weeks to 1 October 2016£000  Audited 52 weeks to 1 April2017 £000  
 Net cash inflow from operating activities                8                                           76,025                                       70,345                                    172,493                               
                                                                                                                                                                                                                                   
 Cash flows from investing activities                                                                                                                                                                                              
 Purchase of property, plant and equipment                                                            (9,134)                                      (10,728)                                  (21,875)                              
 Purchase of computer software                                                                        (972)                                        (702)                                     (2,479)                               
 Purchase of other intangibles                                                                        (117)                                        (209)                                     (281)                                 
 Proceeds from sale of property, plant and equipment                                                  1,177                                        287                                       1,495                                 
 Development costs capitalised                                                                        (5,034)                                      (4,814)                                   (10,731)                              
 Interest received                                                                                    106                                          96                                        211                                   
 Acquisition of businesses, net of cash acquired          10                                          (17,086)                                     (148)                                     (9,972)                               
 Net cash used in investing activities                                                                (31,060)                                     (16,218)                                  (43,632)                              
                                                                                                                                                                                                                                   
 Cash flows from financing activities                                                                                                                                                                                              
 Dividends paid                                                                                       (31,733)                                     (29,609)                                  (49,788)                              
 Purchase of Own shares                                                                               -                                            -                                         (2,368)                               
 Interest paid                                                                                        (3,545)                                      (3,489)                                   (7,023)                               
 Loan arrangement fee paid                                                                            -                                            -                                         (2,656)                               
 Proceeds from bank borrowings                                                                        30,748                                       -                                         -                                     
 Repayment of bank borrowings                                                                         (33,300)                                     -                                         (54,761)                              
 Net cash used in financing activities                                                                (37,830)                                     (33,098)                                  (116,596)                             
                                                                                                                                                                                                                                   
 Increase in cash and cash equivalents                                                                7,135                                        21,029                                    12,265                                
 Cash and cash equivalents brought forward                                                            65,637                                       49,526                                    49,526                                
 Exchange adjustments                                                                                 (1,106)                                      3,713                                     3,846                                 
 Cash and cash equivalents carried forward                                                            71,666                                       74,268                                    65,637                                
                                                                                                                                                                                                                                   
                                                          Unaudited 6 months to30 September 2017£000  Unaudited 26 weeks to 1 October 2016£000     Audited 52 weeks to 1 April2017 £000      
 Reconciliation of net cash flow to movement in net debt                                                                                                                                     
 Increase in cash and cash equivalents                    7,135                                       21,029                                       12,265                                    
 Net cash outflow from repayment of bank borrowings       2,552                                       -                                            54,761                                    
 Loan notes repaid in respect of acquisitions             161                                         241                                          241                                       
 Exchange adjustments                                     5,604                                       (11,873)                                     (16,991)                                  
                                                          15,452                                      9,397                                        50,276                                    
 Net debt brought forward                                 (196,442)                                   (246,718)                                    (246,718)                                 
 Net debt carried forward                                 (180,990)                                   (237,321)                                    (196,442)                                 
 
 
 Notes to the Condensed Financial Statements                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
 1   Basis of preparation General informationThe Half Year Report, which includes the Interim Management Report and Condensed Financial Statements for the 6 months to 30 September 2017, was approved by the Directors on 21 November 2017. Effective from this financial year, the Group changed its reporting basis from weeks to calendar months. The Half Year Report is prepared for the 6 month period to 30 September 2017 and the Annual Report will be prepared for the year to 31 March 2018. For the current         
 financial year, 26 weeks is equivalent to 6 months so there is no difference between presentation on a weekly or calendar months basis. Basis of preparationThe Report has been prepared solely to provide additional information to shareholders as a body to assess the Board's strategies and the potential for those strategies to succeed. It should not be relied on by any other party or for any other purpose. The Report contains certain forward-looking statements which have been made by the Directors in good    
 faith using information available up until the date they approved the Report. Forward-looking statements should be regarded with caution as by their nature such statements involve risk and uncertainties relating to events and circumstances that may occur in the future. Actual results may differ from those expressed in such statements, depending on the outcome of these uncertain future events. The Report has been prepared in accordance with International Accounting Standard 34, applying the accounting       
 policies and presentation that were applied in the preparation of the Group's statutory accounts for the 52 weeks to 1 April 2017, with the exception of the policy for taxes on income, which in the interim period is accrued using the effective tax rate that would be applicable to expected total income for the financial year. The figures shown for the 52 weeks to 1 April 2017 are based on the Group's statutory accounts for that period and do not constitute the Group's statutory accounts for that period as   
 defined in Section 434 of the Companies Act 2006. These statutory accounts, which were prepared under International Financial Reporting Standards, have been filed with the Registrar of Companies. The audit report on those accounts was not qualified, did not include a reference to any matters to which the Auditor drew attention by way of emphasis without qualifying the report, and did not contain statements under Sections 498 (2) or (3) of the Companies Act 2006. Standards and interpretations not yet        
 appliedAt the date of authorisation of this Half Year Report, the following Standards and Interpretations that are potentially relevant to the Group, and which have not been applied in these financial statements, were in issue but not yet effective (and in some cases had not yet been adopted by the EU): -       IFRS 9 'Financial Instruments: Classification and measurement' - effective for accounting periods beginning on or after 1 January 2018.-       IFRS 15 'Revenue from Contracts with Customers' -       
 effective for accounting periods beginning on or after 1 January 2018.-       IFRS 16 'Leases' - effective for accounting periods beginning on or after 1 January 2019.-       Amendments to IFRS 2: Classification and Measurement of Share-based Payment Transactions - effective for accounting periods beginning on or after 1 January 2018.-       Annual Improvements 2014-2016 Cycle - effective for accounting periods beginning on or after 1 January 2018.-       IFRIC Interpretation 22: Foreign Currency           
 Transactions and Advance Consideration - effective for accounting periods beginning on or after 1 January 2018.-       IFRIC Interpretation 23: Uncertainty over Income Tax Treatments - effective for accounting periods beginning on or after 1 January 2019.-       Amendments to IAS 28: Long-term Interests in Associates and Joint Ventures - effective for accounting periods beginning on or after 1 January 2019. The Directors anticipate that the adoption of these Standards and Interpretations in future periods  
 will have no material impact on the financial statements of the Group with the exception of IFRS 9 'Financial Instruments', IFRS 15 'Revenue from Contracts with Customers', and IFRS 16 'Leases' where our review of the impact is ongoing as described below. (a) IFRS 15 'Revenue from Contracts with Customers'For the Group, transition to IFRS 15 will take effect from 1 April 2018. The half year results for FY18/19 will be IFRS 15 compliant with the first Annual Report published in accordance with IFRS 15 being 
 the 31 March 2019 report. The Group plans to adopt a fully retrospective transition approach and so comparatives for the year ended 31 March 2018 will be restated. IFRS 15 sets out the requirements for recognising revenue from contracts with customers. The standard requires entities to apportion revenue earned from contracts to individual promises, or performance obligations, on a stand-alone selling price basis, based on a five-step model. The Group is making good progress in quantifying the full impact of 
 this standard. Having performed an impact assessment in FY16/17, during the first half of FY17/18 the Group has been working through a comprehensive transition exercise at each of its subsidiaries. The autonomous nature of the Group means that each subsidiary sets its own terms and conditions and operating procedures and as such this was the appropriate level for the transition exercise. The transition exercise has involved scoping the Group's revenues to identify revenue streams with like commercial terms 
 and performing sample contract reviews to determine the appropriate revenue recognition under IFRS 15. To ensure a consistent approach to the exercise and consistent judgements, the exercise has been supported from the centre through setting the approach to transition, and providing appropriate tools and guidance, including a revised Group Accounting Manual. The review and conclusion of this exercise is ongoing, including reviewing the consistency of judgements between companies and review by the Group's   
 auditor. Based on the initial views of the companies we do not expect there to be a material change in the timing or quantum of revenue recognition. The following areas of potential differences were identified from our initial impact assessment which are being investigated as part of our transition exercise: -       Certain companies across the Group provide a product which involves an element of customisation. Currently under IAS 18 the revenue recognition for such product is at a point in time on transfer 
 of the risk and reward of the transaction to the customer. IFRS 15 requires that for such transactions, where certain criteria are met, revenue is recognised over time. Based on the review of specific contract terms against the requirements of IFRS 15 we do not currently expect the criteria of IFRS 15 to be met and as such do not expect there to be material change in the timing or quantum of revenue recognition in relation to these arrangements.-       Certain companies across the Group arrange shipping and 
 handling on behalf of their customers but, based on assessment of all terms and conditions, determine control of goods to pass on despatch. Accordingly shipping and handling is a separate performance obligation under IFRS 15 and revenue is only recognised when the performance obligation is fulfilled. Having reviewed the terms of the arrangements we do not currently expect there to be a material change in the timing or quantum of revenue recognition.-       Many of our companies have warranty arrangements   
 with their customers. Having reviewed the details of the warranty arrangements, these have been determined to be of an assurance nature and as such there is no material change in accounting required by IFRS 15.-       Many of the companies have variable consideration arrangements with their customers. Having reviewed the details of these arrangements against IFRS 15 and current accounting practices, we do not currently expect there to be a material change in the timing or quantum of revenue recognition.-    
    Sales commissions and other third-party sales acquisition costs resulting directly from securing contracts with customers are required to be recognised as an asset under IFRS 15 and recognised over the associated contract period where such contract is more than one year in length. Having reviewed the nature of the arrangements we do not currently expect there to be a change in the current accounting.  (b) IFRS 9 'Financial Instruments'For the Group, transition to IFRS 9 will take effect from 1 April     
 2018. The half year results for FY18/19 will be IFRS 9 compliant with the first Annual Report published in accordance with IFRS 9 being the 31 March 2019 report. There is no requirement to restate comparatives. IFRS 9 provides a new expected losses impairment model for financial assets, including trade receivables, and includes amendments to classification and measurement of financial instruments. During this half year the Group has undertaken a high-level review of the impact of this new standard on its   
 financial statements. The Group's use of financial instruments is limited to short-term trading balances such as receivables and payables, borrowings and derivatives used for hedging foreign exchange risks. We therefore expect that the impact of this standard will be limited to classification of financial instruments and the measurement of impairment of short-term financial assets using the expected losses impairment model. Through the second half of the year we will be working to establish an appropriate  
 impairment model and accompanying processes to be applied to receivables by our companies. However, the nature of the financial assets is such that we do not expect there will be a material change in level of impairment recognised compared to that based on current procedures. (c) IFRS 16 'Leases'For the Group, transition to IFRS 16 will take effect from 1 April 2019. The half year results for FY19/20 will be IFRS 16 compliant with the first Annual Report published in accordance with IFRS 16 being for the   
 year ending 31 March 2020. IFRS 16 provides a single model for lessees which recognises a right of use asset and lease liability for all leases which are longer than one year or which are not classified as low value. The distinction between finance and operating leases for lessees is removed. The Group is currently assessing the impact of the new standard. The most significant impact currently identified will be that the Group's land and buildings leases will be brought on to the balance sheet. Further     
 assessment of other leases is currently ongoing. The Group's future lease commitments for land and buildings as at 1 April 2017, which provides an indicator of the value to be brought on to the balance sheet, was £45m. Going concernThe Directors believe the Group is well placed to manage its business risks successfully. The Group's forecasts and projections, taking account of reasonably possible changes in trading performance, show that the Group should be able to operate within the level of its current    
 committed facilities, which includes a £550m five-year Revolving Credit Facility (RCF) completed in November 2016 of which £477m remains undrawn at the date of this report. The RCF was extended to November 2022 following the period end. With this in mind, the Directors have a reasonable expectation that the Company and Group have adequate resources to continue in operational existence for the foreseeable future. Thus they continue to adopt the going concern basis in preparing the half year Condensed        
 Financial Statements.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
 
 
1   Basis of preparation 
 
General information 
 
The Half Year Report, which includes the Interim Management Report and
Condensed Financial Statements for the 6 months to 30 September 2017, was
approved by the Directors on 21 November 2017. Effective from this financial
year, the Group changed its reporting basis from weeks to calendar months. The
Half Year Report is prepared for the 6 month period to 30 September 2017 and
the Annual Report will be prepared for the year to 31 March 2018. For the
current financial year, 26 weeks is equivalent to 6 months so there is no
difference between presentation on a weekly or calendar months basis. 
 
Basis of preparation 
 
The Report has been prepared solely to provide additional information to
shareholders as a body to assess the Board's strategies and the potential for
those strategies to succeed. It should not be relied on by any other party or
for any other purpose. The Report contains certain forward-looking statements
which have been made by the Directors in good faith using information
available up until the date they approved the Report. Forward-looking
statements should be regarded with caution as by their nature such statements
involve risk and uncertainties relating to events and circumstances that may
occur in the future. Actual results may differ from those expressed in such
statements, depending on the outcome of these uncertain future events. The
Report has been prepared in accordance with International Accounting Standard
34, applying the accounting policies and presentation that were applied in the
preparation of the Group's statutory accounts for the 52 weeks to 1 April
2017, with the exception of the policy for taxes on income, which in the
interim period is accrued using the effective tax rate that would be
applicable to expected total income for the financial year. The figures shown
for the 52 weeks to 1 April 2017 are based on the Group's statutory accounts
for that period and do not constitute the Group's statutory accounts for that
period as defined in Section 434 of the Companies Act 2006. These statutory
accounts, which were prepared under International Financial Reporting
Standards, have been filed with the Registrar of Companies. The audit report
on those accounts was not qualified, did not include a reference to any
matters to which the Auditor drew attention by way of emphasis without
qualifying the report, and did not contain statements under Sections 498 (2)
or (3) of the Companies Act 2006. 
 
Standards and interpretations not yet applied 
 
At the date of authorisation of this Half Year Report, the following Standards
and Interpretations that are potentially relevant to the Group, and which have
not been applied in these financial statements, were in issue but not yet
effective (and in some cases had not yet been adopted by the EU): -       IFRS
9 'Financial Instruments: Classification and measurement' - effective for
accounting periods beginning on or after 1 January 2018.-       IFRS 15
'Revenue from Contracts with Customers' - effective for accounting periods
beginning on or after 1 January 2018.-       IFRS 16 'Leases' - effective for
accounting periods beginning on or after 1 January 2019.-       Amendments to
IFRS 2: Classification and Measurement of Share-based Payment Transactions -
effective for accounting periods beginning on or after 1 January 2018.-      
Annual Improvements 2014-2016 Cycle - effective for accounting periods
beginning on or after 1 January 2018.-       IFRIC Interpretation 22: Foreign
Currency Transactions and Advance Consideration - effective for accounting
periods beginning on or after 1 January 2018.-       IFRIC Interpretation 23:
Uncertainty over Income Tax Treatments - effective for accounting periods
beginning on or after 1 January 2019.-       Amendments to IAS 28: Long-term
Interests in Associates and Joint Ventures - effective for accounting periods
beginning on or after 1 January 2019. The Directors anticipate that the
adoption of these Standards and Interpretations in future periods will have no
material impact on the financial statements of the Group with the exception of
IFRS 9 'Financial Instruments', IFRS 15 'Revenue from Contracts with
Customers', and IFRS 16 'Leases' where our review of the impact is ongoing as
described below. 
 
(a) IFRS 15 'Revenue from Contracts with Customers' 
 
For the Group, transition to IFRS 15 will take effect from 1 April 2018. The
half year results for FY18/19 will be IFRS 15 compliant with the first Annual
Report published in accordance with IFRS 15 being the 31 March 2019 report.
The Group plans to adopt a fully retrospective transition approach and so
comparatives for the year ended 31 March 2018 will be restated. IFRS 15 sets
out the requirements for recognising revenue from contracts with customers.
The standard requires entities to apportion revenue earned from contracts to
individual promises, or performance obligations, on a stand-alone selling
price basis, based on a five-step model. The Group is making good progress in
quantifying the full impact of this standard. Having performed an impact
assessment in FY16/17, during the first half of FY17/18 the Group has been
working through a comprehensive transition exercise at each of its
subsidiaries. The autonomous nature of the Group means that each subsidiary
sets its own terms and conditions and operating procedures and as such this
was the appropriate level for the transition exercise. The transition exercise
has involved scoping the Group's revenues to identify revenue streams with
like commercial terms and performing sample contract reviews to determine the
appropriate revenue recognition under IFRS 15. To ensure a consistent approach
to the exercise and consistent judgements, the exercise has been supported
from the centre through setting the approach to transition, and providing
appropriate tools and guidance, including a revised Group Accounting Manual.
The review and conclusion of this exercise is ongoing, including reviewing the
consistency of judgements between companies and review by the Group's auditor.
Based on the initial views of the companies we do not expect there to be a
material change in the timing or quantum of revenue recognition. The following
areas of potential differences were identified from our initial impact
assessment which are being investigated as part of our transition exercise: - 
     Certain companies across the Group provide a product which involves an
element of customisation. Currently under IAS 18 the revenue recognition for
such product is at a point in time on transfer of the risk and reward of the
transaction to the customer. IFRS 15 requires that for such transactions,
where certain criteria are met, revenue is recognised over time. Based on the
review of specific contract terms against the requirements of IFRS 15 we do
not currently expect the criteria of IFRS 15 to be met and as such do not
expect there to be material change in the timing or quantum of revenue
recognition in relation to these arrangements.-       Certain companies across
the Group arrange shipping and handling on behalf of their customers but,
based on assessment of all terms and conditions, determine control of goods to
pass on despatch. Accordingly shipping and handling is a separate performance
obligation under IFRS 15 and revenue is only recognised when the performance
obligation is fulfilled. Having reviewed the terms of the arrangements we do
not currently expect there to be a material change in the timing or quantum of
revenue recognition.-       Many of our companies have warranty arrangements
with their customers. Having reviewed the details of the warranty
arrangements, these have been determined to be of an assurance nature and as
such there is no material change in accounting required by IFRS 15.-      
Many of the companies have variable consideration arrangements with their
customers. Having reviewed the details of these arrangements against IFRS 15
and current accounting practices, we do not currently expect there to be a
material change in the timing or quantum of revenue recognition.-       Sales
commissions and other third-party sales acquisition costs resulting directly
from securing contracts with customers are required to be recognised as an
asset under IFRS 15 and recognised over the associated contract period where
such contract is more than one year in length. Having reviewed the nature of
the arrangements we do not currently expect there to be a change in the
current accounting. 
 
(b) IFRS 9 'Financial Instruments' 
 
For the Group, transition to IFRS 9 will take effect from 1 April 2018. The
half year results for FY18/19 will be IFRS 9 compliant with the first Annual
Report published in accordance with IFRS 9 being the 31 March 2019 report.
There is no requirement to restate comparatives. IFRS 9 provides a new
expected losses impairment model for financial assets, including trade
receivables, and includes amendments to classification and measurement of
financial instruments. During this half year the Group has undertaken a
high-level review of the impact of this new standard on its financial
statements. The Group's use of financial instruments is limited to short-term
trading balances such as receivables and payables, borrowings and derivatives
used for hedging foreign exchange risks. We therefore expect that the impact
of this standard will be limited to classification of financial instruments
and the measurement of impairment of short-term financial assets using the
expected losses impairment model. Through the second half of the year we will
be working to establish an appropriate impairment model and accompanying
processes to be applied to receivables by our companies. However, the nature
of the financial assets is such that we do not expect there will be a material
change in level of impairment recognised compared to that based on current
procedures. 
 
(c) IFRS 16 'Leases' 
 
For the Group, transition to IFRS 16 will take effect from 1 April 2019. The
half year results for FY19/20 will be IFRS 16 compliant with the first Annual
Report published in accordance with IFRS 16 being for the year ending 31 March
2020. IFRS 16 provides a single model for lessees which recognises a right of
use asset and lease liability for all leases which are longer than one year or
which are not classified as low value. The distinction between finance and
operating leases for lessees is removed. The Group is currently assessing the
impact of the new standard. The most significant impact currently identified
will be that the Group's land and buildings leases will be brought on to the
balance sheet. Further assessment of other leases is currently ongoing. The
Group's future lease commitments for land and buildings as at 1 April 2017,
which provides an indicator of the value to be brought on to the balance
sheet, was £45m. 
 
Going concern 
 
The Directors believe the Group is well placed to manage its business risks
successfully. The Group's forecasts and projections, taking account of
reasonably possible changes in trading performance, show that the Group should
be able to operate within the level of its current committed facilities, which
includes a £550m five-year Revolving Credit Facility (RCF) completed in
November 2016 of which £477m remains undrawn at the date of this report. The
RCF was extended to November 2022 following the period end. With this in mind,
the Directors have a reasonable expectation that the Company and Group have
adequate resources to continue in operational existence for the foreseeable
future. Thus they continue to adopt the going concern basis in preparing the
half year Condensed Financial Statements. 
 
 2   Segmental analysis  Sector analysisThe Group has four main reportable segments (Process Safety, Infrastructure Safety, Medical and Environmental & Analysis), which are defined by markets rather than product type. Each segment includes businesses with similar operating and market characteristics. These segments are consistent with the internal reporting as reviewed by the Chief Executive.  
 
 
Sector analysis 
 
The Group has four main reportable segments (Process Safety, Infrastructure
Safety, Medical and Environmental & Analysis), which are defined by markets
rather than product type. Each segment includes businesses with similar
operating and market characteristics. These segments are consistent with the
internal reporting as reviewed by the Chief Executive. 
 
 Segment revenue and results  
 
 
                           Revenue (all continuing operations)          
                           Unaudited 6 months to 30 September 2017£000  Unaudited 26 weeks to 1 October 2016£000  Audited 52 weeks to 1 April2017 £000  
 Process Safety            88,794                                       76,743                                    167,007                               
 Infrastructure Safety     167,923                                      147,988                                   315,219                               
 Medical                   133,270                                      118,664                                   260,576                               
 Environmental & Analysis  116,513                                      98,797                                    219,118                               
 Inter-segmental sales     (171)                                        (71)                                      (258)                                 
 Revenue for the period    506,329                                      442,121                                   961,662                               
 
 
 Inter-segmental sales are charged at prevailing market prices and have not been disclosed separately by segment as they are not considered material. The Group does not analyse revenue by product group. Revenue derived from the rendering of services was £23,399,000 (26 weeks to 1 October 2016: £14,034,000; 52 weeks to 1 April 2017: £39,011,000). All revenue was otherwise derived from the sale of products.  
 
 
                                                   Profit (all continuing operations)           
                                                   Unaudited 6 months to 30 September 2017£000  Unaudited 26 weeks to 1 October 2016£000  Audited 52 weeks to 1 April2017 £000  
 Segment profit before allocation of adjustments*                                                                                                                               
 Process Safety                                    20,247                                       17,395                                    40,243                                
 Infrastructure Safety                             35,736                                       31,991                                    65,129                                
 Medical                                           28,730                                       28,876                                    66,704                                
 Environmental & Analysis                          21,776                                       16,022                                    41,698                                
                                                   106,489                                      94,284                                    213,774                               
 Segment profit after allocation of adjustments*                                                                                                                                
 Process Safety                                    18,227                                       15,491                                    36,243                                
 Infrastructure Safety                             33,177                                       29,735                                    60,342                                
 Medical                                           17,469                                       18,933                                    45,804                                
 Environmental & Analysis                          19,894                                       11,720                                    35,084                                
 Segment profit                                    88,767                                       75,879                                    177,473                               
 Central administration costs                      (7,112)                                      (5,763)                                   (10,484)                              
 Net finance expense                               (4,836)                                      (4,891)                                   (9,286)                               
 Group profit before taxation                      76,819                                       65,225                                    157,703                               
 Taxation                                          (15,104)                                     (13,013)                                  (28,014)                              
 Profit for the period                             61,715                                       52,212                                    129,689                               
 
 
 *     Adjustments include the amortisation and impairment of acquired intangible assets; acquisition items; restructuring costs; and profit or loss on disposal of operations. The accounting policies of the reportable segments are the same as the Group's accounting policies. For acquisitions after 3 April 2010, acquisition transaction costs and adjustments to contingent purchase consideration are recognised in the Consolidated Income Statement. Segment profit before these acquisition costs, the amortisation 
 and impairment of acquired intangible assets, restructuring costs and the profit or loss on disposal of continuing operations is disclosed separately above as this is the measure reported to the Chief Executive for the purpose of allocation of resources and assessment of segment performance. These adjustments are analysed as follows:                                                                                                                                                                                 
 
 
                                                                                                            Unaudited for the 6 months to 30 September 2017  
                                                                                    Acquisition items                                                                                                                                                             
                           Amortisation and impairment of acquired intangibles£000  Transaction costs £000  Adjustments to contingent consideration £000     Release of fair value adjustments to inventory£000  Totalamortisationcharge andacquisitionitems£000  Disposal ofoperations and restructuring£000  Total £000  
 Process Safety            (2,020)                                                  -                       -                                                -                                                   (2,020)                                          -                                            (2,020)     
 Infrastructure Safety     (2,456)                                                  (103)                   -                                                -                                                   (2,559)                                          -                                            (2,559)     
 Medical                   (9,941)                                                  (826)                   (494)                                            -                                                   (11,261)                                         -                                            (11,261)    
 Environmental & Analysis  (2,899)                                                  (3)                     1,121                                            (101)                                               (1,882)                                          -                                            (1,882)     
 Total Segment & Group     (17,316)                                                 (932)                   627                                              (101)                                               (17,722)                                         -                                            (17,722)    
 
 
 The transaction costs arose mainly on the acquisitions of CasMed NIBP and Cardios during the period. Further detail on the acquisitions is contained in note 10. The £627,000 adjustment to contingent consideration comprises a credit of £1,121,000 in Environmental & Analysis arising from a change in estimate of the payable for FluxData, Inc. (FluxData), a prior year acquisition, offset by £494,000 in Medical arising from exchange differences on the payables for Visiometrics S.L. (Visiometrics) which is       
 denominated in Euros and for Cardios which is denominated in Brazilian Reals. The £101,000 charge relates to the release of the remaining fair value adjustment on revaluing the inventory of FluxData on acquisition in the prior year.                                                                                                                                                                                                                                                                                        
 
 
                                                                                                                                                          Unaudited for the 26 weeks to 1 October 2016        
                                                                                    Acquisition items                                                                                                                                                               
                           Amortisation and impairment of acquired intangibles£000  Transaction costs £000  Adjustments to contingent consideration £000  Release of fair value adjustments to inventory£000  Total amortisation charge and acquisition items £000  Disposal of operations and restructuring£000  Total £000  
 Process Safety            (1,904)                                                  -                       -                                             -                                                   (1,904)                                               -                                             (1,904)     
 Infrastructure Safety     (2,256)                                                  -                       -                                             -                                                   (2,256)                                               -                                             (2,256)     
 Medical                   (8,815)                                                  -                       (338)                                         (790)                                               (9,943)                                               -                                             (9,943)     
 Environmental & Analysis  (2,217)                                                  -                       15                                            -                                                   (2,202)                                               (2,100)                                       (4,302)     
 Total Segment & Group     (15,192)                                                 -                       (323)                                         (790)                                               (16,305)                                              (2,100)                                       (18,405)    
 
 
 The £338,000 charge to contingent consideration comprises a credit arising from a revision to the estimate of the payable for Value Added Solutions LLC (VAS) by £339,000 offset by a £677,000 charge arising from changes in the discount rate along with exchange differences on the payable for Visiometrics which is denominated in Euros. The £790,000 charge relates to the release of the remaining fair value adjustment on revaluing the inventory of CenTrak Inc (CenTrak) on acquisition. The £2,100,000 charge      
 relates to inventory and fixed asset write downs and severance costs arising on the restructuring of non-core operations in one of the Group's subsidiaries, Pixelteq Inc (Pixelteq).                                                                                                                                                                                                                                                                                                                                           
 
 
                                                                                                            Audited for the 52 weeks ended 1 April 2017   
                                                                                    Acquisition items                                                                                                                                                          
                           Amortisation and impairment of acquired intangibles£000  Transaction costs £000  Adjustments to contingent consideration £000  Release of fair value adjustments to inventory£000  Totalamortisationcharge andacquisitionitems£000  Disposal ofoperations and restructuring£000  Total £000  
 Process Safety            (4,000)                                                  -                       -                                             -                                                   (4,000)                                          -                                            (4,000)     
 Infrastructure Safety     (4,784)                                                  (3)                     -                                             -                                                   (4,787)                                          -                                            (4,787)     
 Medical                   (30,702)                       

- More to follow, for following part double click  ID:nRSU0273Xc

Recent news on Halma

See all news